Impact of Histopathological Prostate Inflammation on Urine-Based Prostate Cancer Prediction Using the Prostate Cancer Gene 3 Score
-
Published:2020
Issue:5-6
Volume:104
Page:483-488
-
ISSN:0042-1138
-
Container-title:Urologia Internationalis
-
language:en
-
Short-container-title:Urol Int
Author:
Hennenlotter JörgORCID,
Neumann Tim,
Perner Sven,
Wagner Viktoria,
Stenzl Arnulf,
Todenhöfer Tilman,
Rausch Steffen
Reference14 articles.
1. de la Taille A. Progensa PCA3 test for prostate cancer detection. Expert Rev Mol Diagn. 2007 Sep;7(5):491–7.
2. Groskopf J, Aubin SM, Deras IL, Blase A, Bodrug S, Clark C, et al. APTIMA PCA3 molecular urine test: development of a method to aid in the diagnosis of prostate cancer. Clin Chem. 2006 Jun;52(6):1089–95.
3. Albino G, Capoluongo E, Rocchetti S, Palumbo S, Zuppi C, Cirillo-Marucco E. Evaluation of the diagnostic and predictive power of PCA3 in the prostate cancer. A different best cut-off in each different scenario. Preliminary results. Arch Ital Urol Androl. 2014 Dec;86(4):306–10.
4. Klatte T, Waldert M, de Martino M, Schatzl G, Mannhalter C, Remzi M. Age-specific PCA3 score reference values for diagnosis of prostate cancer. World J Urol. 2012 Jun;30(3):405–10.
5. Gui-Zhong L, Libo M, Guanglin H, Jianwei W. The correlation of extent and grade of inflammation with serum PSA levels in patients with IV prostatitis. Int Urol Nephrol. 2011 Jun;43(2):295–301.